An Observational Cross-Sectional Study of Gender and Disability as Determinants of Person-Centered Medicine in Botulinum Neurotoxin Treatment of Upper Motoneuron Syndrome

The motor behaviour of patients with Upper Motor Neuron Syndrome (UMNS) is characterised by spasticity. The first-line treatment for this clinical condition is Botulinum neurotoxin A (BoNTA), but the number and key locations of muscles which need to be treated is not much discussed in the literature...

Descripción completa

Detalles Bibliográficos
Autores principales: Del Prete, Cristina Maria, Viva, Mattia Giuseppe, De Trane, Stefania, Brindisino, Fabrizio, Barassi, Giovanni, Specchia, Alessandro, Di Iorio, Angelo, Pellegrino, Raffaello
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024520/
https://www.ncbi.nlm.nih.gov/pubmed/35448855
http://dx.doi.org/10.3390/toxins14040246

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024520/
https://www.ncbi.nlm.nih.gov/pubmed/35448855
http://dx.doi.org/10.3390/toxins14040246

Ejemplares similares